These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9501773)

  • 21. Cochrane made simple. Anti-D administration during pregnancy for preventing Rhesus isoimmunisation.
    Anderson T
    Pract Midwife; 1999 Jun; 2(6):10. PubMed ID: 10481667
    [No Abstract]   [Full Text] [Related]  

  • 22. Costs and clinical outcomes of noninvasive fetal RhD typing for targeted prophylaxis.
    Hawk AF; Chang EY; Shields SM; Simpson KN
    Obstet Gynecol; 2013 Sep; 122(3):579-85. PubMed ID: 23921866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prophylactic anti-D for RhD- patient in France: an hasty recommendation?].
    Benachi A; Nisand I
    J Gynecol Obstet Biol Reprod (Paris); 2007 Oct; 36(6):523-5. PubMed ID: 17651919
    [No Abstract]   [Full Text] [Related]  

  • 24. Is Rh immune globulin needed in early first-trimester abortion? A review.
    Jabara S; Barnhart KT
    Am J Obstet Gynecol; 2003 Mar; 188(3):623-7. PubMed ID: 12634631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The science of consensus.
    Br J Obstet Gynaecol; 1998 Feb; 105(2):vii. PubMed ID: 9501769
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevention of RhD Alloimmunization: A Comparison of Four National Guidelines.
    Sperling JD; Dahlke JD; Sutton D; Gonzalez JM; Chauhan SP
    Am J Perinatol; 2018 Jan; 35(2):110-119. PubMed ID: 28910850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Royal College of Physicians of Edinburgh/Royal College of Obstetricians and Gynaecologists Consensus Conference on anti-D prophylaxis, 7-8 April 1997.
    Br J Haematol; 1997 Jun; 97(4):927-8. PubMed ID: 9217199
    [No Abstract]   [Full Text] [Related]  

  • 28. Estimating the cost of Rh testing and prophylaxis in early pregnancy: A time-driven activity-based costing study.
    Gilmore EV; Russell LB; Harvie HS; Schreiber CA
    Contraception; 2024 Aug; 136():110468. PubMed ID: 38648923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevention of Rh immunization. II. Management of the risk during the second half of pregnancy and postpartum].
    Larsen JF; Bock JE; Jørgensen JR
    Ugeskr Laeger; 2004 Aug; 166(36):3078-83. PubMed ID: 15387304
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical guidelines on anti-D prophylaxis: hasty critics?].
    Carbonne B; Marpeau L; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2007 Oct; 36(6):526-8. PubMed ID: 17893030
    [No Abstract]   [Full Text] [Related]  

  • 31. [Economic analysis of the prevention of anti-D immunization].
    Ravinet J; Carbonne B
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S104-1S111. PubMed ID: 16495835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RhD immunisation in pregnancy.
    Akkök ÇA; Eggebø TM; Kiserud T; Heier HE
    Tidsskr Nor Laegeforen; 2016 May; 136(8):724-6. PubMed ID: 27143464
    [No Abstract]   [Full Text] [Related]  

  • 33. Compliance with routine antenatal rhesus D prophylaxis and the impact on sensitisations: observations over 14 years.
    MacKenzie IZ; Findlay J; Thompson K; Roseman F
    BJOG; 2006 Jul; 113(7):839-43. PubMed ID: 16827770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventing RhD haemolytic disease of the newborn. Guidelines are not followed in many cases.
    McFadyen IR; Martlew VJ; Howard HL; Clarke CA
    BMJ; 1998 Apr; 316(7138):1165. PubMed ID: 9569417
    [No Abstract]   [Full Text] [Related]  

  • 35. Anti-D immunoglobulin prophylaxis--are we doing enough?
    Drug Ther Bull; 1985 Dec; 23(24):93-5. PubMed ID: 2998720
    [No Abstract]   [Full Text] [Related]  

  • 36. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 37. [RhD immunoprophylaxis should be adjusted].
    Bock JE; Larsen JF
    Ugeskr Laeger; 2004 Aug; 166(36):3113. PubMed ID: 15387315
    [No Abstract]   [Full Text] [Related]  

  • 38. Anti-D guidelines.
    Kanjilal K; Tasker M
    Br J Fam Plann; 2000 Oct; 26(4):244. PubMed ID: 11053891
    [No Abstract]   [Full Text] [Related]  

  • 39. RCM challenges new anti-D guidelines.
    Pract Midwife; 1999 Nov; 2(10):7. PubMed ID: 12024565
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hemolytic disease of the newborn has not vanished from Finland--routine protection of RhD negative mothers during pregnancy is justifiable].
    Sainio S; Kuosmanen M
    Duodecim; 2012; 128(2):151-7. PubMed ID: 22372070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.